Pancreatic Cancer Research

ResearcherSichuan UniversityActive in the last 2 years

Yuan Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6324-6134; OpenAlex author ID A5100344865. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 2

  1. The Immunomechanical Checkpoint PYK2 Governs Monocyte-to-Macrophage Differentiation in Pancreatic Cancer. Co-author DOI 10.1158/2159-8290.cd-24-1712↗
  2. Efficacy and safety of gemcitabine plus erlotinib for locally advanced or metastatic pancreatic cancer: a systematic review and meta-analysis. Co-author DOI 10.2147/dddt.s105442↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Wenyan Xie · 1 shared paper, 2025 · strength 0.20
  2. Jie Yang · 1 shared paper, 2025 · strength 0.20
  3. Hong Jiang · 1 shared paper, 2025 · strength 0.20
  4. Yunhua Liu · 1 shared paper, 2025 · strength 0.20
  5. Hubing Shi · 1 shared paper, 2025 · strength 0.20
  6. Nengwen Ke · 1 shared paper, 2025 · strength 0.20
  7. Zhehai Wang · 1 shared paper, 2016 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.